Reversed-Phase Chromatography Columns Market Global Report 2026

The reversed-phase chromatography columns market size has grown strongly in recent years. It will grow from $0.9 billion in 2025 to $0.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in pharmaceutical R&D activities, rising adoption of HPLC techniques in laboratories, expansion of biotechnology research programs, increasing regulatory requirements for analytical testing, and growing demand for protein and peptide purification.

The reversed-phase chromatography columns market size is expected to see strong growth in the next few years. It will grow to $1.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth during the forecast period can be attributed to increasing demand for precision medicine research applications, expansion in biologics and biosimilars development, rising investments in advanced chromatography technologies, broader use in pharmaceutical quality assurance processes, and growing emphasis on high-throughput analytical workflows. Major trends expected in the forecast period include wider adoption of UHPLC columns, rising demand for high-purity protein and peptide purification processes, increased use of microbore columns for enhanced sensitivity analysis, advancement of hybrid and monolithic column materials, and expanding application of chromatography techniques in quality control and analytical testing.

The expansion of personalized medicine is expected to drive the growth of the reversed-phase chromatography columns market going forward. Personalized medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual’s genetic profile to improve clinical outcomes. The growth of personalized medicine is driven by the rising adoption of genomic technologies, which enable healthcare providers to design targeted therapies based on an individual’s genetic makeup, enhancing diagnostic precision and treatment effectiveness. Reversed-phase chromatography columns support personalized medicine by enabling precise separation and analysis of complex biological molecules for accurate biomarker identification, targeted drug development, and patient-specific therapeutic monitoring. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the number of new personalized therapies approved by the FDA for patients with rare diseases increased from six in 2022 to 16 in 2023. Therefore, the expansion of personalized medicine is expected to drive the growth of the reversed-phase chromatography columns market.

Key companies operating in the reversed-phase chromatography columns market are focusing on developing technologically advanced solutions, such as microflow liquid chromatography (LC) columns, to enhance analytical sensitivity while reducing sample and solvent consumption in high-precision bioanalytical and pharmaceutical applications. Microflow liquid chromatography (LC) columns are chromatography columns that operate at very low flow rates and small internal diameters, enabling highly sensitive analyte detection while using minimal sample and solvent volumes. For example, in February 2026, Waters Corporation, a US-based analytical laboratory instrumentation company, launched next-generation 1 mm I.D. liquid chromatography columns equipped with MaxPeak Premier Technology across its ACQUITY, BioResolve, and GTxResolve column portfolios. These microflow columns are designed to significantly enhance detection sensitivity while reducing solvent and sample consumption, making them particularly valuable in bioanalysis, pharmaceutical discovery and development, and omics-based research areas such as metabolomics, proteomics, and lipidomics, where sample volumes are often limited. The MaxPeak Premier Technology incorporated in these columns helps minimize metal-analyte interactions, improving accuracy and reproducibility for challenging biomolecules compared to conventional stainless-steel column designs. The system is already being deployed in high-performance laboratory workflows where sensitivity and efficiency are critical performance parameters.

In December 2025, Römer Industries Holding GmbH, a Germany-based manufacturing company, acquired VDS optilab Chromatographietechnik GmbH for an undisclosed value. Through this acquisition, Römer Industries Holding GmbH aims to strengthen its presence in the analytical instrumentation and chromatography sector by expanding its product portfolio and enhancing its capabilities in high-precision separation technologies used in pharmaceutical and bioanalytical applications. VDS optilab Chromatographietechnik GmbH is a Germany-based company that provides a wide range of reversed-phase (RP) chromatography columns.

Major companies operating in the reversed-phase chromatography columns market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Waters Corporation, Merck KGaA, Phenomenex Inc., Shimadzu Corporation, Tosoh Corporation, YMC Co. Ltd., Osaka Soda Co. Ltd., Daicel Corporation, Biotage AB, GL Sciences Inc., Restek Corporation, Hamilton Company, KNAUER Wissenschaftliche Geräte GmbH, SiliCycle Inc., Dikma Technologies Inc., Yamazen Corporation, Imtakt Corporation, Sepax Technologies Inc., Orochem Technologies Inc., MicroSolv Technology Corporation.

North America was the dominant region in the reversed-phase chromatography columns market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in reversed-phase chromatography columns report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the reversed-phase chromatography columns market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reversed-phase chromatography columns market includes revenues earned by entities by providing services such as analytical testing, sample analysis, column performance evaluation, and technical support for separation and purification processes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The reversed-phase chromatography columns market consists of sales of C18 columns, C8 columns, phenyl columns, and cyano (CN) columns. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reversed-phase chromatography columns market research report is one of a series of new reports that provides reversed-phase chromatography columns market statistics, including reversed-phase chromatography columns industry global market size, regional shares, competitors with a reversed-phase chromatography columns market share, detailed reversed-phase chromatography columns market segments, market trends and opportunities, and any further data you may need to thrive in the reversed-phase chromatography columns industry. This reversed-phase chromatography columns market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.